65% Of Americans Say They'd Use Medical Marijuana Under A Clinician For Anxiety, Pain And Sleep

Provider of clinically guided cannabis health and wellness solutions EO Care, Inc., released this week's results of its new survey showing Americans' views on marijuana and consumption habits. All of the 1,027 survey participants were employed at least part-time and are from states where cannabis is legal either for medical or adult use.

Survey Highlights

• 18% of respondents have used cannabis for health reasons in the past year, 19% have used it recreationally and 14% have used it for both purposes.

• The top three reasons for their marijuana consumption are anxiety, pain and as a sleep aid. 88% of medical marijuana users say it reduced their use of prescription drugs, alcohol or both.

• 51% said they would be likely/very likely to use cannabis if it were offered by their health plan.

• 65% of respondents said they would feel more comfortable using cannabis if it were screened and dosed by a clinician.

• 56% of respondents said they would be more likely to take a job at a company whose health plan offered cannabis care.

• 44% would reconsider applying for a job at a company that tested for prior use of cannabis use or prohibited cannabis consumption outside of the workplace.

“Finding clinical guidance for medicinal cannabis is difficult because most doctors lack the knowledge and retail dispensaries are not equipped to provide medical advice,” stated Sean Collins, co-founder and CEO of EO Care. “As a result we have tens of millions of Americans using cannabis for health reasons without guidance on specific product recommendations, dosage amounts, possible drug interactions, or consideration of their health history and other potential health risks. Given that sales of cannabis for health reasons is far higher than most prescription drugs, this is a highly concerning situation for healthcare generally.”

See Also: Empowering Cancer Patients With Informed Cannabis Support: A Partnership That Matters

Did you miss the first wave of cannabis investments? Don’t make that mistake again.

 Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger’s sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.

Photo: Benzinga edit with images by Africa Studio on Shutterstock